Denmark-based allergy and immunotherapy company ALK plans to maintain the company's focus on digital offers such as consumer-oriented services,for which reason it nominates the former head of consumer healthcare at Sanofi, Alan Main, for a place on the board of the firm at the future general meeting, which is scheduled for March next year, according to an ALK press release.
If shareholders formally vote Main into the board, he will be taking over after Vincent Warnery, who was elected for the ALK board in March 2019 with the hopes that he could help boost the consumer healthcare business.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Rumored purchase of GN Group could mean divestment of hearing aid division, says media
Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
EMA publishes new plan to support antibiotic development
Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
(Senior) Drug Substance Specialist 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Industrial Designer- Design Engineer 
Clinical Trial Administrator 
Biomarker Operations Lead 
Chemist for Incoming Materials in QC Department 
2 Sales Representatives and Product Specialists 
Senior Project Manager (GMP - Life Science) 
Client Talent Acquisition Specialist 
Senior Manager, Clinical Trial Budget 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Account Manager 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Key Account Manager, Europe and Asia 
Clinical Trial Manager 
Nordic Medical Affairs Manager